Form 4: GoodRx CFO Executes Restricted Stock Unit Conversion

GoodRx Holdings CFO Christopher A. McGinnis acquired 44,779 shares through RSU vesting and disposed of 19,726 shares to cover tax obligations.

Summary

• CFO Christopher A. McGinnis exercised 44,779 restricted stock units (RSUs) on May 15, 2026.
• The transaction resulted in a net increase of 25,053 shares held by the executive.
• 19,726 shares were withheld by the company at a price of $2.49 per share to satisfy tax withholding requirements.
• Following these transactions, the CFO holds 177,616 shares of Class A common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative action related to executive compensation rather than a strategic or market-driven decision.

Positives

• The transaction reflects the standard vesting schedule of executive equity compensation.
• The executive maintains a significant direct ownership stake of 177,616 shares.

Negatives

• The disposal of 19,726 shares, while for tax purposes, reduces the total potential equity stake held by the executive.

Risks

• Equity-based compensation is subject to market volatility, which may impact the value of future vesting tranches.

Future Outlook

The remaining 492,580 unvested restricted stock units are scheduled to vest in equal quarterly installments over the next 12 quarters.

Management Comments

• No specific narrative comments were provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that routine RSU vesting and tax-related sell-to-cover transactions are standard corporate governance practices and generally do not signal a change in executive sentiment regarding company performance.

Comparison to Industry Standards

• The transaction structure is consistent with standard executive compensation practices observed in the healthcare technology sector.
• The use of sell-to-cover for tax obligations is a common practice among publicly traded companies to manage executive tax liabilities.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard equity compensation event.

Next Steps

• Continued quarterly vesting of remaining 492,580 restricted stock units.

Key Dates

Keywords

GoodRx, GDRX, Insider Trading, Form 4, Executive Compensation, CFO